U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07097987) titled 'Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion' on July 30.
Brief Summary: The goal of this clinical trial is to evaluate the physiological effects of a WM Formula on glucagon-like peptide-1 (GLP-1) secretion and glycemic regulation in adults with elevated body fat percentage. The WM Formula is a multi-component dietary supplement composed of Bifidobacterium breve (probiotic), ClpB Formula-a prebiotic blend containing probiotic kombucha extract, soy peptide powder, L-arabinose, and erythritol-and rocket apple extract.
Participants enrolled in the study will be required to undergo blood collection...